Agency Information Collection Activities: Submission for OMB Review; Comment Request, 7401-7402 [2021-01896]
Download as PDF
<![CDATA[
7401
Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Rapid Response Suicide Investigation
Data Collection (OMB Control No.
0920–1243, Exp. 09/30/2021)—
Extension—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC is frequently called upon to
respond to urgent requests from one or
more external partners (e.g., local, state,
territory, and tribal health authorities;
other federal agencies; local and state
leaders; schools; or other partner
organizations) to conduct investigations
of suicide. Supporting rapid
investigations to inform the
implementation of effective suicide
prevention strategies is one of the most
important ways CDC can serve to
protect and promote the health of the
public.
Rapid Response Suicide Investigation
Data Collections are specifically
designed to inform the implementation
of prevention strategies in a state,
county, community, or vulnerable
population where a possible suicide
cluster or increasing trend has been
observed. This generic clearance will
not be used to conduct research studies
or to collect data designed to draw
conclusions about the United States or
areas beyond the defined geographic
location or vulnerable population that is
the focus of the investigation. CDC in
collaboration with external partners
(e.g., local, state, territory, and tribal
health authorities; other federal
agencies; local and state leaders;
schools; or other partner organizations)
will identify the respondent universe for
each Rapid Response Suicide
Investigation Data Collection. The
respondent universe will be determined
based on the information needed to
understand potential suicide clusters,
significant increases in suicidal
behavior and suicide, risk and
protective factors, and vulnerable
populations in order to inform the
implementation of suicide prevention
strategies. When the goal is
generalizability, CDC will submit the
sampling methods to OMB as part of the
GenIC package. The estimated annual
burden hours are 1,000. There are no
costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Rapid Response Suicide Investigation Data Collection
Participants.
Rapid Response Suicide Investigation Protocol.
2,000
1
30/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–01917 Filed 1–27–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10332]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
SUMMARY:
VerDate Sep<11>2014
17:16 Jan 27, 2021
Jkt 253001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
E:\FR\FM\28JAN1.SGM
28JAN1
7402
Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by March 1, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Disclosure
Requirement for the In-Office Ancillary
Services Exception; Use: Section 6003 of
the Affordable Care Act (ACA)
established a new disclosure
requirement that a physician must
perform for certain imaging services to
meet the in-office ancillary services
VerDate Sep<11>2014
17:16 Jan 27, 2021
Jkt 253001
exception to the prohibition of the
physician self-referral law. This section
of the ACA amended section 1877(b)(2)
of the Act by adding a requirement that
the referring physician informs the
patient, at the time of the referral and in
writing, that the patient may receive the
imaging service from another supplier.
Physicians who provide certain
imaging services (MRI, CT, and PET)
under the in-office ancillary services
exception to the physician self-referral
prohibition are required to provide the
disclosure notice as well as the list of
other imaging suppliers to the patient.
The patient will then be able to use the
disclosure notice and list of suppliers in
making an informed decision about his
or her course of care for the imaging
service.
CMS would use the collected
information for enforcement purposes.
Specifically, if we were investigating the
referrals of a physician providing
advanced imaging services under the inoffice ancillary services exception, we
would review the written disclosure in
order to determine if it satisfied the
requirement. Form Number: CMS–
10332 (OMB control number: 0938–
1133); Frequency: Occasionally;
Affected Public: Private Sector, Business
or other for-profits, Not-for-profits
institutions; Number of Respondents:
2,239; Total Annual Responses:
989,971; Total Annual Hours: 18,694.
(For questions regarding this collection
contact Laura Dash at 410–786–8623.)
Dated: January 25, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–01896 Filed 1–27–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Childhood Vaccines
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Childhood Vaccines
(ACCV) will hold public meetings for
the 2021 calendar year (CY).
Information about the ACCV, agendas,
and materials for these meetings can be
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
found on the ACCV website at https://
www.hrsa.gov/advisory-committees/
vaccines.
ACCV meetings will be held on:
• March 4, 2021, 10:00 a.m. Eastern
Time (ET)–4:00 p.m. ET;
• June 3, 2021, 10:00 a.m. ET–4:00
p.m. ET;
• September 2, 2021, 10:00 a.m. ET–
4:00 p.m. ET;
• December 2, 2021, 10:00 a.m. ET–
4:00 p.m. ET.
ADDRESSES: Meetings may be held inperson or by teleconference and
webinar. For updates on how the
meeting will be held, visit the ACCV
website 30 business days before the date
of the meeting, where instructions for
joining meetings either in-person and
remotely will also be posted. In-person
ACCV meetings will be held at 5600
Fishers Lane, Rockville, Maryland
20857. For meeting information
updates, go to the ACCV website listed
above.
FOR FURTHER INFORMATION CONTACT:
Annie Herzog, Division of Injury
Compensation Programs, HRSA, 5600
Fishers Lane, Rockville, Maryland
20857; 301–443–6634; or ACCV@
HRSA.gov.
DATES:
The ACCV
provides advice and recommendations
to the Secretary of HHS on policy,
program development, and other issues
related to implementation of the
National Vaccine Injury Compensation
Program (VICP) and concerning other
matters as described under section 2119
of the Public Health Service Act (42
U.S.C. 300aa–19).
Since priorities dictate meeting times,
be advised that times and agenda items
are subject to change. Refer to the ACCV
website listed above for any meeting
updates that may occur. For CY 2021
meetings, agenda items may include,
but are not limited to updates from the
Division of Injury Compensation
Programs, Department of Justice, Office
of Infectious Disease and HIV/AIDS
Policy (HHS), Immunization Safety
Office (Centers for Disease Control and
Prevention), National Institute of
Allergy and Infectious Diseases
(National Institutes of Health) and
Center for Biologics, Evaluation and
Research (Food and Drug
Administration). Refer to the ACCV
website listed above for all current and
updated information concerning the CY
2021 ACCV meetings, including draft
agendas and meeting materials that will
be posted 5 calendar days before the
meeting(s).
Members of the public will have the
opportunity to provide comments.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 86, Number 17 (Thursday, January 28, 2021)]
[Notices]
[Pages 7401-7402]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01896]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10332]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use
[[Page 7402]]
of automated collection techniques or other forms of information
technology to minimize the information collection burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by March 1, 2021.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Disclosure
Requirement for the In-Office Ancillary Services Exception; Use:
Section 6003 of the Affordable Care Act (ACA) established a new
disclosure requirement that a physician must perform for certain
imaging services to meet the in-office ancillary services exception to
the prohibition of the physician self-referral law. This section of the
ACA amended section 1877(b)(2) of the Act by adding a requirement that
the referring physician informs the patient, at the time of the
referral and in writing, that the patient may receive the imaging
service from another supplier.
Physicians who provide certain imaging services (MRI, CT, and PET)
under the in-office ancillary services exception to the physician self-
referral prohibition are required to provide the disclosure notice as
well as the list of other imaging suppliers to the patient. The patient
will then be able to use the disclosure notice and list of suppliers in
making an informed decision about his or her course of care for the
imaging service.
CMS would use the collected information for enforcement purposes.
Specifically, if we were investigating the referrals of a physician
providing advanced imaging services under the in- office ancillary
services exception, we would review the written disclosure in order to
determine if it satisfied the requirement. Form Number: CMS-10332 (OMB
control number: 0938-1133); Frequency: Occasionally; Affected Public:
Private Sector, Business or other for-profits, Not-for-profits
institutions; Number of Respondents: 2,239; Total Annual Responses:
989,971; Total Annual Hours: 18,694. (For questions regarding this
collection contact Laura Dash at 410-786-8623.)
Dated: January 25, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2021-01896 Filed 1-27-21; 8:45 am]
BILLING CODE 4120-01-P
